Concentrix (CNXC) Cash & Equivalents (2020 - 2026)

Concentrix has disclosed Cash & Equivalents across 7 years of filings, most recently posting $222.7 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $222.7 million, down 27.7% year-over-year; the trailing twelve-month figure through Feb 2026 was $222.7 million (down 27.7% YoY), and the FY2025 annual result was $327.3 million, up 36.07% from the prior year.
• Cash & Equivalents came in at $222.7 million for Q1 2026 at Concentrix, down from $327.3 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $2.1 billion in Q3 2023 to a low of $142.2 million in Q1 2022.
• The 5-year median for Cash & Equivalents is $234.8 million (2024), against an average of $344.6 million.
• Across the five-year window, Cash & Equivalents surged 1099.89% in 2023 and slumped 88.35% in 2024, its largest moves.
• Concentrix's Cash & Equivalents stood at $157.5 million in 2022, then jumped by 87.56% to $295.3 million in 2023, then declined by 18.54% to $240.6 million in 2024, then soared by 36.07% to $327.3 million in 2025, then slumped by 31.97% to $222.7 million in 2026.
• The last three Cash & Equivalents figures came in at $222.7 million (Q1 2026), $327.3 million (Q4 2025), and $350.3 million (Q3 2025), per Business Quant data.